Efficacy of Combination Therapy with Glycyrrhizinate, Antiallergic Agent, and Low Dose Steroid for Lenalidomide-induced Skin Eruptions in a Patient with Refractory Multiple Myeloma
スポンサーリンク
概要
- 論文の詳細を見る
A 61-year-old man with refractory myeloma was treated using lenalidomide(LEN)as salvage therapy. Three days after initiating LEN therapy, skin eruptions appeared on his limbs and extremities. The eruptions rapidly disappeared on discontinuing LEN and initiating therapy with low-dose prednisolone(10 mg/day),olopatadine, and intravenous glycyrrhizinate. The eruptions recurred at the time that LEN was readministered and did not disappear on administering only prednisolone and olopatadine. Additional therapy with oral glycyrrhizinate effectively controlled the eruptions, and therefore, the patient was allowed to continue LEN therapy.
- 山口大学医学会の論文
山口大学医学会 | 論文
- 3.当科における特発性および膠原病性間質性肺炎の検討(一般演題I,第17回山口大学医学部第二内科飛翔会循環器研究会)
- NO.17 当科における特発性および膠原病性間質性肺炎の検討(一般演題,講演抄録,第109回山口大学医学会学術講演会)
- NO.8 心不全における心房性利尿ペプチドの抗酸化作用による心筋保護効果の検討(一般演題,講演抄録,第111回山口大学医学会学術講演会)
- 3. Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy
- NO.7致死的不整脈発症要因としてのリアノジン受容体機能異常(一般演題,第108回山口大学医学会学術講演会並びに平成19年度総会)